C5-9 deficiency

• Terminal complement pathway deficiency is a genetic condition affecting the complement membrane attack complex (MAC)

• Suspect terminal complement pathway deficiency with patients who have more than one episode of Neisseria infection.

• Patients with terminal complement pathway deficiency should receive meningococcal and pneumococcal vaccinations. They can receive live vaccines.